99% Savings - Buy Just @1 Rs X
Ampirok 500/250 Injection is a prescription drug, available for use as Injection. The alternative uses of Ampirok 500/250 Injection have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Ampirok 500/250 Injection. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Some other side effects of Ampirok 500/250 Injection have been listed ahead. Such side effects of Ampirok 500/250 Injection normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Ampirok 500/250 Injection's effect is Safe during pregnancy and Safe for lactating mothers. Warnings related to Ampirok 500/250 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Ampirok 500/250 Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Ampirok 500/250 Injection in conditions like Kidney Disease, Kidney Disease, Jaundice. The section on Ampirok 500/250 Injection contraindications lists all such conditions.
Besides this, Ampirok 500/250 Injection may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Ampirok 500/250 Injection is considered not safe while driving, and is not addictive.
Ampirok 500/250 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Ampirok 500/250 Injection is used -
Moderate
Mild
Is the use of Ampirok 500/250 Injection safe for pregnant women?
Pregnant women can take Ampirok safely.
Is the use of Ampirok 500/250 Injection safe during breastfeeding?
Breastfeeding women can safely use Ampirok.
What is the effect of Ampirok 500/250 Injection on the Kidneys?
Ampirok may have mild side effects on the kidneys.
What is the effect of Ampirok 500/250 Injection on the Liver?
Using Ampirok does not have any harmful effects on the liver.
What is the effect of Ampirok 500/250 Injection on the Heart?
You can take Ampirok without any fear of damage to the heart.
If you are suffering from any of the following diseases, you should not take Ampirok 500/250 Injection unless your doctor advises you to do so -
Is this Ampirok 500/250 Injection habit forming or addictive?
No, you will not get addicted to Ampirok 500/250 Injection.
Interaction between Food and Ampirok 500/250 Injection
Ampirok 500/250 Injection may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Ampirok 500/250 Injection
It is difficult to say anything about the effect of Ampirok 500/250 Injection and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ampicillin
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 722-723
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 158-160
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; UNASYN® (ampicillin sodium/sulbactam sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 725
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 160-162